Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol Maleate Gel in Superficial Infantile Hemangioma (Proliferative Phase)
CTR20202613Phase 2Completed
- Sponsor
- Mersen Pharmaceutical
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol in Capillary Haemangioma, sponsored by Mersen Pharmaceutical. Started Dec 2020; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20202613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202613.